&w=3840&q=100)
Chalet Hotels shares jump 19% post Q1; analyst decodes stock strategy
At the time of writing this report, around 7.5 million shares had changed hands on the counter, cumulatively, on the NSE and BSE. While the stock experienced a strong rally earlier in the day, nearly all gains were erased post-noon.
Chalet Hotels Q1FY26 earnings
The company's overall income for the quarter ended June 30, 2025, stood at ₹908 crore, as compared to ₹369 crore reported in the corresponding period of the previous fiscal year, indicating a triple-digit increase of 146 per cent. Consolidated net profit for Q1FY26 stood at ₹203.1 crore, up by 235 per cent year from ₹60 crore recorded in the same period of the last financial year. Chalet Hotel's operating margin for the quarter stood at 35 per cent during the quarter under review. The figure stood at 30 per cent during the first quarter of the last financial year. However, it is worth mentioning that Chalet Hotels' Q1FY26 performance is not directly comparable on a year-on-year (Y-o-Y) basis, as the company has accounted for both revenue and expenses related to its residential projects in Bengaluru during this quarter.
Earnings before interest, taxes, depreciation and amortisation (Ebitda) stood at ₹371 crore in Q1FY26, marking a 150 per cent Y-o-Y increase from ₹148 crore recorded in Q1FY25. Chalet Hotel's revenue per available room (RevPar) also surged 10 per cent Y-o-Y to ₹805 crore in Q1FY26.
'Despite the geopolitical headwinds across India and West Asia, we've once again delivered a strong quarterly performance— a reflection of our team's unwavering commitment to disciplined execution, guest-centricity, and long-term value creation," said Sanjay Sethi, managing director and CEO, Chalet Hotels.
As per the company release, Sethi will be succeeded by Shwetank Singh, who will assume the role of managing director and CEO effective February 1, 2026. "Over the past two years, we've also been thoughtfully preparing for the future of leadership at Chalet. In alignment with a well-crafted succession plan developed in collaboration with the Board, I had communicated my intent not to seek an extension of my current term, which concludes on January 31, 2026," Sethi said.
Brokerage View- Religare Broking
So far this calendar year, Chalet Hotels stock has struggled to trade in the green territory, experiencing a decline of around 7 per cent. While the overall outlook of the stock remains on the positive side, Ravi Singh, SVP-retail research at Religare Broking, advised investors to buy on prospective dips.
"Chalet Hotels shares opened with a gap up of nearly 10 per cent after its announcement of Q1 results for FY26. Previously, the stock has been trading in higher high and higher lows structure, which indicates bullishness in every dip. Traders and investor can initiate 'Buy on Dip' strategy in this stock with a support level of ₹960 for upside potential of 10-15 per cent with risk managed to 5 per cent downside (below ₹915). Overall sentiments remain on positive side as per technical charts and volume accumulation," he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
37 minutes ago
- Indian Express
Private promoter ownership dips to 8-year low in June 2025 quarter
Private promoters holding in the domestic capital market declined to an eight-year low of 40.58 per cent during the quarter ended June 30, down from 40.81 per cent as on March 31, 2025. In the April-June 2025 quarter, promoters sold Rs 54,732 crore worth of their holding on a net basis. In rupee value terms, private promoter holding stood at Rs 184.61 lakh crore as on June 30, 2025, according to a report by PRIME Database Group. This analysis is based on shareholding patterns filed by 2,086 of the total 2,131 companies listed on NSE (main board) for the quarter ending June 30, 2025. 'While promoter buying is always a positive sign, promoter selling can be due to a wide variety of reasons such as promoters taking advantage of bullish markets to take money off the table, strategic reasons like debt reduction, legacy planning, philanthropy, investment in other ventures and meeting Minimum Public Shareholding (MPS) requirement as also for personal expenses,' said Pranav Haldea, managing director, PRIME Database Group. Besides, relatively lower promoter holding in some of the recent IPO companies and overall institutionalisation of market are also the other reasons behind decline in promoter shareholding. Some of the companies that saw the highest selling, on a net basis, by private promoters in the June 2025 quarter included Bharti Airtel (Rs 13,059 crore), Interglobe Aviation (Rs 11,863 crore), Vishal Mega Mart (Rs 11,215 crore), Samvardhana Motherson International Ltd (Rs 6,227 crore), and Bajaj Finserv Ltd. (Rs 5,725 crore). In the June 2025 quarter, domestic institutional investors (DIIs) continued their dominance in the stock market, the report showed. The share of domestic institutional investors (DIIs) touched an all-time high of 17.82 per cent as on June 30, 2025, up from 17.62 per cent as on March 31, 2025, following a net investment of Rs 1.68 lakh crore during the April-June period, the report said On the other hand, the share of foreign institutional investors (FIIs), declined further to a 13-year low of 17.04 per cent from 17.22 per cent during the previous quarter, despite a net inflow of Rs 38,674 crore (inflow of Rs 29,793 in secondary market and inflow of Rs 8,881 crore in primary market). The increase in DIIs' share was mainly on account of domestic mutual funds (MFs) that are flush with retail money coming through systematic investment plan (SIPs). They invested Rs 1.17 lakh crore on a net basis during the quarter. Mutual funds' share in NSE listed companies reached an all-time high of 10.56 per cent as on June 30, 2025 (up from 10.35 per cent). Besides, mutual fund players, the domestic insurance companies too invested Rs 8,076 crore on net basis during the quarter even though their overall share went down from 5.40 per cent to 5.30 per cent, the report said.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Chinese investor Ant Group may exit Paytm after offloading 5.84% stake
Ant Group is expected to offload its remaining 5.84% stake in Paytm worth $434 million, marking a potential exit from the fintech firm. The deal comes amid growing regulatory concerns Mumbai Chinese investor Ant Group is expected to exit fintech major Paytm by offloading its remaining 5.84% stake through block deals worth approximately $434 million, according to a report by Reuters. Ant is anticipated to sell the stake at a floor price of ₹1,020 per share. This represents a 5.4% discount to Paytm's closing price of ₹1,078.30 per share on August 4 on the Bombay Stock Exchange (BSE). Goldman Sachs India Securities and Citigroup Global Markets India are expected to lead the sale. In May, it sold about 4% of its total holding in Paytm operator One97 Communications. As of the March 2025 (Q4FY25) quarter, its stake in the company stood at 9.85%. In August 2023, it had offloaded a 10.3% stake in the company. Prior to that, the investor held a 23.79% stake in Paytm as of the June 2023 (Q1FY24) quarter, according to data from the BSE. The sale of the stake comes amid regulatory scrutiny regarding investments by Chinese-origin investors. The first quarter of 2025-26 (Q1FY26) turned profitable for One97 Communications, the parent company of fintech player Paytm, after a steep loss of ₹838.9 crore in Q1FY25. The net profit of ₹122.5 crore in Q1FY26 was largely driven by sharp cost controls. The fintech firm had posted a net loss of ₹539.8 crore in Q4FY25.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales
Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to ₹824 crore for the June quarter, hit by dip in sales in the US and API business vertical. The Hyderabad-based drug maker posted a net profit of ₹918 crore for the April-June quarter of last fiscal. Revenue from operations increased to ₹7,868 crore for the June quarter as against ₹7,567 crore in the year-ago period, Aurobindo Pharma said in a regulatory filing. "We started the year steadily, with our European business maintaining strong growth momentum and our core US business showing resilience despite temporary challenges from destocking and seasonal dynamics," K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said. The company's disciplined execution, operational initiatives, and recent US acquisition strengthens commercial footprint and accelerates growth potential, he added. The board of directors at its meeting held on Monday has approved the payment of interim dividend of 400% i.e ₹4.00 per equity share of ₹1. /- each on equity share capital of the company. The company has fixed August 8, 2025, as the record date for purpose of the payment of interim dividend. Shares of the company on Monday ended 1.04 per cent up at ₹1,090.90 apiece on BSE. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
